|
|
Viracept (Nelfinavir)
| Brand Name: |
Viracept |
| Generic Name: |
Nelfinavir, NFV |
| Adult Single Dose: |
Two 625-mg tablets (twice a day) OR
three 250-mg tablets (three times a day) OR five 250-mg tablets (twice
a day) |
| Food & Liquid Restrictions: |
Take with a meal |
| Drug Class: |
PI |
The Basics
- An Overview of Viracept (Nelfinavir) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
- Viracept (Nelfinavir, NFV) (January/February 2008)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Viracept (Nelfinavir) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- Nelfinavir (Viracept) (September 20, 2007)
To read PDF, click here
From AIDS InfoNet
- Patient Information About Viracept (Nelfinavir) (PDF) (August 2007)
From Pfizer, Inc.
- Nelfinavir (Viracept) (August 15, 2006)
From AIDS Treatment Data Network
- Viracept (Nelfinavir) (May 2005)
To read PDF, click here
From The Center for AIDS
- Drug Interactions: Nelfinavir (August 2004)
From Project Inform
- Bon Appetite -- Using Food to Boost Your Viracept (July/August 2003)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Why It's Important to Eat When Taking Viracept (August/September 2002)
In Reasons for Hope, from Search for a Cure
News
- Viracept (Nelfinavir Mesylate) 250 mg, 625 mg Tablets, and Powder for Oral Suspension: Important Information for Prescribers (PDF) (May 6, 2008)
From Pfizer, Inc.
- Heavy Restrictions on Nelfinavir Use Recommended for Pediatric Patients, Pregnant Women in United States (September 10, 2007)
From U.S. Food and Drug Administration
- European Union Suspends Roche HIV Drug Due to Toxic Contamination (August 7, 2007)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Roche Admits Long-Standing, Low-Level Contamination of Nelfinavir (July 26, 2007)
New information reveals contamination dating back to the drug's release in 1998; United States, Canada and Japan are the only unaffected countries.
From aidsmap.com
- Viracept Recall Creates Panic in Zambia (June 19, 2007)
From United Nations Integrated Regional Information Networks
- European Medicines Agency Recalls Roche Antiretroviral Viracept Because of Contamination (June 8, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- New Nelfinavir Formulation Now Available for Patients With HIV (June 1, 2004)
A Pfizer press release on nelfinavir's new twice-a-day dosing option.
From Pfizer, Inc.
- Nelfinavir Available in 625 mg Formulation in United States (May 25, 2004)
The new dosing may allow Americans on the drug to switch from five to two doses daily.
From HIV InSite
- Pfizer Announces Two-Year Price Freeze for ADAP Drug (March 21, 2002)
In AIDS Action Weekly Update, from AIDS Action Council
- Caution With Nelfinavir and Some Lipid-Lowering Drugs (November 21, 2001)
From Canadian AIDS Treatment Information Exchange
- Nelfinavir Potency Concerns (April 2000)
In Project Inform Perspective, from Project Inform
- Treatment Briefs: Nelfinavir -- Twice Daily Use and New Formulation (Spring 2000)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Updates: Twice-daily Nelfinavir (Spring 2000)
In STEP Perspective, from Seattle Treatment Education Project
- Twice-Daily Viracept Dosing OK'd (February 2000)
In Positive Living, from AIDS Project Los Angeles
- Nelfinavir (Viracept®) Price Increase 4.6% (October 16, 1998)
From AIDS Treatment News
- Nelfinavir Becomes Fourth Protease Inhibitor to Hit Pharmacy Shelves (April 1997)
From Treatment Action Group
- FDA Approves Nelfinavir, Ritonavir Approved for Children, More Pharmacies to Carry Crixivan (March 1997)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Expanding Information on Nelfinavir, the Next Protease Inhibitor (January 1997)
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
|
|
